THYROCARE.BOTHYROCARE.BO
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +19.84% | +23.14% | +21.34% | +23.02% | +22.09% |
| Gross Profit Growth | +25.75% | +113.77% | +223.78% | +92.52% | +33.31% |
| EBITDA Growth | +27.51% | +33.28% | +67.00% | +35.47% | +47.01% |
| Operating Income Growth | +31.08% | +36.15% | +111.71% | +48.21% | +69.90% |
| Net Income Growth | +31.19% | +24.50% | +22.05% | +61.27% | +79.94% |
| EPS Growth | +29.95% | +28.78% | +24.11% | +61.18% | +81.56% |
| EPS Diluted Growth | +29.69% | +28.52% | +23.81% | +62.53% | +81.93% |
| Weighted Average Shares Growth | +0.98% | +0.81% | -1.49% | +0.15% | -0.85% |
| Weighted Average Shares Diluted Growth | +1.18% | -3.13% | -5.87% | -0.77% | -1.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -13.42% | +0.00% | +5.39% | +0.00% | +57.50% |
| Inventory Growth | +36.52% | +0.00% | +53.62% | +0.00% | -13.96% |
| Asset Growth | +0.74% | +0.00% | +7.59% | +0.00% | +13.92% |
| Book Value per Share Growth | -0.58% | -0.59% | +5.36% | +3.52% | +10.37% |
| Debt Growth | -60.55% | +0.00% | -41.71% | +0.00% | +33.05% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +22.15% | -100.00% | -55.14% | -100.00% | +6.79% |